Core Viewpoint - The A-share market experienced a strong start in the first week of 2026, with significant inflows of leveraged funds, indicating a positive market sentiment and potential investment opportunities [2][5][18]. Group 1: Market Performance - The first week of 2026 saw a net inflow of financing funds reaching 857.79 billion yuan, ranking fifth in A-share history for single-week net inflows [2][5]. - The total trading volume in the A-share market exceeded 30 trillion yuan on January 9, reflecting heightened market activity and investor interest [4]. - Daily net inflows for the first four days of the week were substantial, exceeding 100 billion yuan each day, with figures of 192.66 billion, 188.87 billion, 249.02 billion, and 159.44 billion yuan respectively [6]. Group 2: Sector Focus - The electronic sector attracted the most attention from financing clients, with a net inflow of 158.12 billion yuan, significantly higher than other sectors [12]. - The non-ferrous metals sector followed with a net inflow of 95.62 billion yuan, while the defense and military industry saw an increase of 91.73 billion yuan, indicating growing interest in these areas [13]. - Other sectors such as non-bank financials and computers also received over 60 billion yuan in net financing [14]. Group 3: Investor Behavior - Investors showed a strong inclination towards short-term operations, primarily chasing hot themes, with many existing clients increasing their positions rather than new account openings [3][9]. - Over 70% of the stocks in the financing market experienced net buying, with seven stocks exceeding 1 billion yuan in net inflows, including significant contributions from XW Communication and China Ping An [15][16]. Group 4: Future Outlook - Analysts suggest that the current market momentum is supported by multiple liquidity factors, including abnormal inflows into A500 ETF and the continuous appreciation of the yuan, which reflects international confidence in China [18][19]. - The spring market is expected to have further room for growth, with technology sectors likely to remain a long-term focus, while value sectors may also present opportunities [20][21]. - Short-term market dynamics may shift, with potential changes in sentiment and policy risks to be monitored, but overall risks are considered manageable [22].

Core Viewpoint - The A-share market experienced a strong performance with the Shanghai Composite Index rising by 1.09%, and the total trading volume exceeding 3.64 trillion yuan, marking a historical high [1]. Market Performance - The three major indices opened strong and closed higher, with the Shanghai Composite Index up by 1.09%, the Shenzhen Component Index up by 1.75%, and the ChiNext Index up by 1.82% [1]. - Over 4,100 stocks in the market saw an increase in value [1]. Sector Performance - The commercial aerospace sector showed robust performance, with companies like China Satellite and Aerospace Electronics hitting the daily limit [1]. - Brain-computer interface concept stocks surged, with Nanjing Panda achieving five consecutive daily limits [1]. - Controlled nuclear fusion concept stocks were active, with Falunsheng hitting the daily limit and Haheng Huaton rising over 11% [1]. - Sectors such as digital media, military electronics, software services, and cloud services had significant gains [1]. - Conversely, sectors like insurance, petrochemicals, and coal experienced declines [1].

Core Viewpoint - Shanghai Hanxun (300762.SZ) has not yet engaged in brain-computer interface related business and continues to focus on special broadband communication and low-orbit satellite fields, providing reliable communication solutions for industry clients [1] Group 1 - The company currently does not have any operations related to brain-computer interfaces [1] - The company's long-term focus is on special broadband communication and low-orbit satellite sectors [1] - The company aims to provide high-reliability communication solutions for its industry clients [1]

Investment Rating - The report maintains a positive outlook on innovative drugs and the related industry chain, indicating potential value revaluation for specific pharmaceutical companies [6][28]. Core Insights - The pharmaceutical sector in A-shares showed strong performance in the second week of January 2026, with the SW Pharma Bio index rising by 7.8%, outperforming the overall market [8][29]. - Key sub-sectors such as medical services (+12.3%), medical equipment (+9.4%), and chemical preparations (+7.3%) demonstrated significant growth during this period [13][29]. - Notable individual stock performances included Innovative Medical Management (+61.0%), Sanbo Hospital Management Group (+56.2%), and MeHow Medical (+56.1%) [15][29]. - The report highlights a normal premium level of 68.3% for the pharmaceutical sector relative to all A-shares as of January 9, 2026 [15][23]. Summary by Sections 1. Continued Focus on Innovative Drugs and Industry Chain - The report emphasizes the high prosperity in innovative drugs and suggests monitoring companies like Jiangsu Heng Rui Medicine, Hansoh Pharmaceutical, 3SBio, Sichuan Kelun Pharmaceutical, and Jiangsu Nhwa Pharmaceutical for potential value revaluation [6][28]. 2. Performance of A-Shares Pharmaceutical Sector - In the second week of January 2026, the A-share pharmaceutical sector outperformed the market, with the SW Pharma Bio index increasing by 7.8% [8][29]. - The report ranks the pharmaceutical sector as the 5th best-performing industry among Shenwan's primary industries during this period [11][29]. 3. Performance of Hong Kong and U.S. Pharmaceutical Sectors - The Hong Kong pharmaceutical sector outperformed the market, with the Hang Seng Healthcare index rising by 10.3% and the biotechnology sector increasing by 11.1% [20][29]. - Conversely, the U.S. pharmaceutical sector underperformed, with the S&P Healthcare Select Sector rising by only 1.1% compared to the S&P 500's 1.6% increase [20][29].

Core Viewpoint - BrainCo, a non-invasive brain-computer interface technology company based in Hangzhou, has reportedly submitted a confidential IPO application to the Hong Kong Stock Exchange, aiming to raise several hundred million dollars [1] Group 1: Company Overview - BrainCo is a member of the "Hangzhou Six Little Dragons" and recently completed a financing round of 2 billion yuan [1] - The latest financing round was led by IDG Capital and Huaden International, founded by Intel CEO Chen Lifeng, with participation from various institutions including Lens Technology, Huazhu Group, Linying Intelligent Manufacturing, and TAL Education [1] - The funds raised will be used for core technology research and development, engineering breakthroughs, and product mass production [1] Group 2: Technology and Achievements - Established in 2015, BrainCo is the first Chinese team selected for Harvard University's Innovation Lab and holds over 460 authorized patents [1] - The company has developed a smart bionic hand that has received FDA approval in the United States and CE certification in Europe, applicable in rehabilitation, health, and human-computer interaction fields [1] - BrainCo has been recognized as a key enterprise for introduction by the Hong Kong government [1] Group 3: Market Context - Another company within the "Hangzhou Six Little Dragons," Qunke Technology, has submitted two applications for listing on the Hong Kong Stock Exchange and is still in the approval process [1] - The group is gaining attention in the capital market due to breakthroughs in artificial intelligence and robotics [1]

Market Overview - The market continued to rise with all three major indices closing higher, and trading volume exceeded 3.6 trillion, setting a new record since October 8, 2024 [1] - Over 4,100 stocks rose, indicating strong market momentum [1] Sector Performance - The GEO concept saw a strong surge, with stocks like Yidian Tianxia, Zhongwen Online, and Tianlong Group hitting a 20% limit up [1] - The commercial aerospace sector also performed well, with China Satellite, a leading player, hitting the limit up [1] - The photovoltaic sector rose, with stocks like Maiwei Co. and Dongfang Risheng increasing over 10% [2] - The robotics sector experienced upward movement, with stocks like Aowei New Materials reaching historical highs [2] Key Stocks - Tianpu Co., a 16-fold bull stock, faced a one-day limit down due to a significant announcement regarding trading anomalies [2] - The overall market saw 4,144 stocks rise and 1,182 fall, with 202 stocks hitting the limit up and 9 hitting the limit down [2] Fund Flow - Main funds focused on software development, IT services, and computer equipment, with notable net inflows into stocks like Yanshan Technology, China Satellite, and Haige Communication [3] Industry Insights - The Brain-Machine Interface (BMI) technology is projected to have significant applications in healthcare, consumer electronics, and military aerospace, indicating a transformative potential for future economic cycles [4] - The Ministry of Industry and Information Technology emphasized the importance of stabilizing growth in ten key industries, which account for 80% of industrial output [5] - Several storage and packaging companies have raised prices by approximately 30% due to high demand and full capacity utilization, with potential for further price increases [6] Future Market Outlook - Huaxi Securities suggests that the spring bullish window may continue, supported by positive PMI and inflation data, as well as increased market participation from external funds [8] - Huatai Securities indicates that the spring market may still have room for growth, recommending focus on gaming, duty-free, and battery sectors [9] - CITIC Construction emphasizes the positive impact of investment and demand-side policies, suggesting attention to cyclical sectors like steel structure and infrastructure [10]

Core Viewpoint - The article emphasizes the importance of bridging the technology chain and completing the talent chain to promote the application of brain-computer interface (BCI) technology, highlighting the achievements of Tianjin University's Brain-Computer Interaction and Human-Machine Integration Haihe Laboratory in this field [1] Group 1: Technological Advancements - The Tianjin University team focuses on non-invasive brain-computer interfaces, driving technological innovation and industrial application [1] - A comprehensive layout has been established, covering high-performance devices, chips, algorithms, platforms, system integration, and key applications [1] Group 2: Clinical Applications - The "Shengong" brain-computer interaction medical device series has been developed, addressing clinical applications such as stroke rehabilitation, spinal cord injury assistance, depression treatment, and auditory disorders [1] Group 3: Aerospace Applications - The design and development of the fifth-generation space station's in-orbit brain-computer interaction system have been completed, enabling the first "space brain-computer interface experiment" [1] - Subsequent manned flight missions have achieved significant applications, enhancing astronauts' functional and emotional state detection, providing critical technical support for China's next-generation medical and human factors assurance system in manned spaceflight [1]

Group 1 - The company, Shanghai Hanxun (300762.SZ), has not yet engaged in brain-computer interface related business [1] - The company focuses on special broadband communication and low-orbit satellite fields [1] - The company is committed to providing high-reliability communication solutions for industry clients [1]

Market Performance - The Shanghai Composite Index rose by 1.09% to close at 4165.29 points, while the Shenzhen Component Index increased by 1.75% to 14366.91 points, and the ChiNext Index gained 1.82% to 3388.34 points [1] - The North Stock 50 surged by 5.35% to 1605.77 points, with the total market turnover reaching 36,445 billion yuan, an increase of 4,922 billion yuan compared to the previous day, marking a historical high [1] Sector Highlights - The AI application sector showed significant activity, with stocks such as Yidian Tianxia (301171), Zhidema (300785), and Kunlun Wanwei (300418) hitting the 20% daily limit up, while companies like Liou Co. (002131) and Vision China (000681) also reached the limit [1] - The commercial aerospace sector strengthened, with Xingtou Measurement and Control hitting a 30% limit up, and Tianyin Machinery (300342) and Ligong Navigation also reaching the 20% limit up [1] - The brain-computer interface sector continued to perform well in the afternoon, with Daoshi Technology (300409) hitting a 20% limit up, alongside Yanshan Technology (002195) and Haige Communication (002465) [1] - The insurance sector experienced a correction, with China Ping An and China Pacific Insurance (601601) both declining over 2% [1]

人民财讯1月12日电，脑机交互与人机共融海河实验室今日官微消息，脑机交互与人机共融海河实验室 主任、天津大学副校长明东表示，脑机接口在医疗健康、消费电子、军事航天等多个领域均展现出巨大 的应用前景和市场潜力。脑机接口一旦实现产业化以及规模化应用，必将为人类生产生活方式带来颠覆 性变革，其发展必将成为影响未来世界经济周期的重要变量之一，也是影响未来世界经济格局的一大重 要因素。因此，突破脑机接口技术封锁，发展自主可控的脑机接口关键技术与核心元器件事关我国新型 工业化发展和国家经济安全。 ...